CDT Equity Inc. Share Price
NASDAQ: CDT | Micro CapCDT Equity Inc. Stock Performance
CDT Equity Inc. Share Price Today
As of 19 September 2026, CDT Equity Inc.'s share price is $0.17. The stock opened at $0.16, compared to its previous close of $0.19. During today's trading session, CDT Equity Inc.'s share price traded between $0.16 and $0.17, with an average price of $0.17. Over the past 52 weeks, the stock has recorded a high of $9.81 and a low of $0.16. In terms of performance, CDT Equity Inc.'s share price has declined by 97.07% over the last six months and is down 74.22% on a year-on-year basis.
CDT Equity Inc. Share Price Chart
CDT Equity Inc. Quarterly Profit & Loss
All figures in USD
CDT Equity Inc. Annual Profit & Loss
All figures in USD
About CDT Equity Inc.
Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was founded in 2019 and is based in Naples, Florida.
CDT Equity Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Sep 2026 | $1.51 | $0.17 | -90.98% |
Aug 2026 | $2.92 | $1.89 | -35.88% |
Jul 2026 | $0.55 | $2.94 | +413.09% |
Jun 2026 | $0.91 | $0.57 | -45.94% |
May 2026 | $2.23 | $1.06 | -54.41% |
Apr 2026 | $5.03 | $2.33 | -60.02% |
Mar 2026 | $0.65 | $5.82 | +752.64% |
Feb 2026 | $1.10 | $0.68 | -37.43% |
Jan 2026 | $1.32 | $1.09 | -15.50% |
Dec 2025 | $1.71 | $1.29 | -35.79% |
Nov 2025 | $2.69 | $2.01 | -31.43% |
Oct 2025 | $0.67 | $2.93 | +343.27% |